期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 218, 期 9, 页码 -出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20210009
关键词
-
资金
- National Natural Science Foundation of China [81830017, 81902433, 81902051]
- National Outstanding Youth Science Fund Project of National Natural Science Foundation of China [81425012]
- Taishan Scholar Foundation of Shandong Province [tspd20181201]
- Collaborative Innovation Center of Technology and Equipment for Biological Diagnosis and Therapy in Universities of Shandong
- Key Research and DevelopmentProgram of Shandong [2018YFJH0503]
- National Key Research and Development Program [2018YFE0126500]
The study identifies Zhx2 as a novel negative regulator that restricts NK cell maturation and function, with its loss enhancing NK cell survival and response to IL-15. Zhx2 deficiency in NK cells inhibits tumor growth and metastasis, highlighting its therapeutic potential for enhancing NK cell-mediated tumor surveillance.
The maturation and functional competence of natural killer (NK) cells is a tightly controlled process that relies on transcription factors (TFs). Here, we identify transcriptional repressor zinc fingers and homeoboxes 2 (Zhx2) as a novel regulator that restricts NK cell maturation and function. Mice with Zhx2 conditional deletion in NK cells (Zhx2(Delta/Delta)) showed accumulation of matured NK cells. Loss of Zhx2 enhanced NK cell survival and NK cell response to IL-15. Transcriptomic analysis revealed Zeb2, a key TF in NK cell terminal maturation, as a direct downstream target of Zhx2. Therapeutically, transfer of Zhx2-deficient NK cells resulted in inhibition of tumor growth and metastasis in different murine models. Our findings collectively unmask a previously unrecognized role of Zhx2 as a novel negative regulator in NK cell maturation and highlight its therapeutic potential as a promising strategy to enhance NK cell-mediated tumor surveillance.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据